Mechelen, Belgium; Galapagos NV (Euronext: GLPG) announced today that it has entered into a multi-year global strategic alliance with Merck & Co., Inc. to develop potential new therapies in obesity and diabetes. Galapagos will be responsible for the ...
Read more...
Long shunned by regulators and ignored by food and beverage processors in the U.S., the natural non-calorie sweetener known as rebaudioside A, an extract derived from the green leaves of the stevia plant, is coming to the rescue of the soda pop ...
Read more...
Diabetes IS the name of a disorder in which the body has trouble regulating its carbohydrate and lipid metabolism. Untreated, it leads to elevated sugar levels. Diabetes is a disease that can strike children of all ages and across all backgrounds. It ...
Read more...
January 9, 2009 — The Advisory Committee on Immunization Practices (ACIP) has issued the recommended adult immunization schedule for 2009, published in the January 9 issue of the Morbidity and Mortality Weekly Report . The 2009 schedule has been ...
Read more...
Eli Lilly and Company (NYSE: LLY) announced that it received a complete response letter from the U.S. Food and Drug Administration (FDA) for olanzapine long-acting injection (LAI) for acute and maintenance treatment of schizophrenia in adults. Lilly ...
Read more...
Eli Lilly and Company has announced that it received a complete response letter from the U.S. Food and Drug Administration (FDA) for olanzapine long-acting injection (LAI) for acute and maintenance treatment of schizophrenia in adults. Lilly is ...
Read more...
(RTTNews) - Wednesday, Eli Lilly and Co. (LLY: News ) announced that it has received a complete response letter from the U.S. Food and Drug Administration for olanzapine long-acting injection or LAI for acute and maintenance treatment of ...
Read more...